- The Daily Rip India by Stocktwits
- Posts
- Where Do We Go From Here?
Where Do We Go From Here?

Tale of the Tape
Good evening everyone.
Markets tanked in the last two hours of trading, with the Nifty and Sensex ending down -1.1% each. Concerns over US debt rating downgrade + profit booking in bluechip heavyweights dampened sentiment. Midcaps (-0.9%) and Smallcaps (-1.6%) also saw deep cuts. 408 stocks in the NSE 500 were down.
It was a sea of red across sectors. Auto (-2.2%) saw the most selling pressure, followed by FMCG (-1.3%) and Pharma (-1.3%).
Pfizer jumped +9% after handing out an extremely juicy dividend. Meanwhile DLF (+3%) was up on a solid Q4 show. More details below.
Belrise Industries IPO kicks off tomorrow! Check out our analysis below to help you decide whether to subscribe.
HAL, Mobikwik and Restaurant Brands Asia saw big moves. Look at their charts below to find out why.
Eternal (-4%) aka Zomato was the top Nifty loser after Jefferies said a foreign ownership cap could see the stock leaving MSCI indices. PS - this could see an outflow of $1.3 billion.
Easy Trip Planners cracked -5% after reports said promoter Nishant Pitti was being probed for his role in the Mahadev app betting scam.
Q4 reactions. Power Grid Corporation was down -2% after it missed Street estimates.GMR Power (-3%) fell after reporting more than a -600 bps YoY drop in margins.
M&A. Waaree Energies forayed into transformer manufacturing. Nazara Technologies will buy UK-based games publisher Curve Games for Rs 247 cr.
Ashok Leyland will consider the proposal of a bonus issue on May 23.
Nifty | 24,684 | -1.1% |
Sensex | 81,186 | -1.1% |
Bank Nifty | 54,877 | -1.0% |
Earnings
Earnings Roundup
DLF (+4%) posted solid Q4 numbers! Robust demand for luxury residential projects juiced up its topline. FYI - Q4 pre-sales grew +39% YoY to Rs 2,000 cr, while collections were up +54% YoY to hit Rs 3,300 cr. This was partly due to its ‘One Midtown’ and ‘The Dahlia’s projects. Fun fact: The Dahlias saw a whopping Rs 13,744 cr in sales during FY25, accounting for more than half of its overall bookings.
As a result, its net cash position hit an insane Rs 6,8458 cr as of March 2025. Finally, the firm’s office vertical saw rental occupancy levels gradually improve to a “healthy” 94%. PS - Jefferies is bullish and has a target price of Rs 1,000 p/sh; +30% from current levels.
Here are its key stats:
Revenue: Rs 3,128 cr; +47% YoY
EBITDA: Rs 978 cr; +30% YoY
PAT: Rs 1,282 cr; +36% YoY
DLF is -7% YTD.
What’s your view on the stock? |
Pfizer jumped +11% intraday after reporting solid Q4 results. Strong demand for vaccines, heart drugs & painkillers helped bump up the topline. Lower raw material costs + a richer product mix helped lift up margins, which in turn juiced up Q4 profits.
But the real reason why investors are so excited is that the company declared a whopping Rs 165 p/sh dividend, its highest in 12 years! FYI - this is broken down into a final dividend of Rs 35 p/sh, a special dividend of Rs 100 p/sh and then another Rs 30 p/sh dividend due to some land deal transaction going through. Not bad at all!
Here are its key stats:
Revenue: Rs 592 cr; +8% YoY
EBITDA: Rs 228 cr; +20% YoY
EBITDA Margin: 38.4% vs 27.1%
PAT: Rs 331 cr; +85% YoY
Pfizer is -7% YTD.
Specials
5 Stocks Under Rs 500 - By SEBI RAs
As markets recover, which stocks should be on your radar? Check out the top Mid and Small Cap stocks under ₹500 with massive upside potential, as shared by SEBI RAs on Stocktwits.